Access the full text.
Sign up today, get DeepDyve free for 14 days.
James Wilson (2016)
Public Value, Maximization and Health Policy: An Examination of Hausman’s Restricted ConsequentialismPublic Health Ethics, 10
The Economic Journal, 118
E. Nord (1993)
The trade-off between severity of illness and treatment effect in cost-value analysis of health care.Health policy, 24 3
E. Nord (2016)
Public Values for Health States Versus Societal Valuations of Health Improvements: A Critique of Dan Hausman’s ‘Valuing Health’Public Health Ethics, 10
A. Oliver (2017)
Distinguishing between experienced utility and remembered utilityPublic Health Ethics, 10
A. Williams (1990)
EuroQol : a new facility for the measurement of health-related quality of lifeHealth Policy, 16
P. Dolan, D. Kahneman (2008)
Interpretations of Utility and Their Implications for the Valuation of HealthHealth Economics
D. Hausman (2015)
Valuing Health: Well-Being, Freedom, and Suffering
D. Hausman (2017)
Responses to My CriticsPublic Health Ethics, 10
Alex Voorhoeve (2015)
Why One Should Count only Claims with which One Can SympathizePublic Health eJournal
Elselijn Kingma (2017)
Health, Disease and Naturalism: Hausman on the Public Value of HealthPublic Health Ethics, 10
C. Murray, Alan Lopez (2013)
Measuring the global burden of disease.The New England journal of medicine, 369 5
E. Nord (1999)
Cost-Value Analysis in Health Care: Making Sense out of QALYS
H. Bleichrodt, M. Johannesson (1997)
Standard gamble, time trade-off and rating scale: experimental results on the ranking properties of QALYs.Journal of health economics, 16 2
A. Alexandrova (2016)
Is Well-being Measurable After All?Public Health Ethics, 10
AbstractThis article introduces a symposium on Daniel Hausman’s Valuing Health: Well-Being, Suffering and Freedom (OUP, 2015). The symposium contains papers by Elselijn Kingma, Adam Oliver, Anna Alexandrova, Erik Nord, Alex Voorhoeve and James Wilson, with replies by Daniel Hausman. In Valuing Health, Hausman argues that, despite apparently measuring health, projects such as the Global Burden of Disease Study in fact measure judgments about the value of health. Once this has been clarified, the key question is how the value of health should be measured. Hausman argues that existing instruments measure the private value of health, that is, health’s ‘contribution to whatever the individual cares about or should care about’, whereas what should be measured for resource allocation purposes is the public value of health, that is, the value health should be accorded from the perspective of the liberal state. Hausman argues that the public value of health should be measured by the extent to which (i) suffering and (ii) activity limitations are relieved. Each commentator engages with a different aspect of Hausman’s argument.
Public Health Ethics – Oxford University Press
Published: Jul 1, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.